Zina Affas Besse

Director/Board Member at

Alydia Health, Inc.

Health Technology

Finance

Consumer Services

Profile

Zina Affas Besse currently holds the position of Director at Eyenuk, Inc. since 2022.
Also holds the role of Director at Alydia Health, Inc. The role of Director at LimmaTech Biologics AG has been held since 2023.
Serves as Partner at AXA IM Alts since 2022.
Acts as Advisor at LHGP Asset Management LLP (Private Equity).
Education includes undergraduate and doctorate degrees from the University of Nottingham Malaysia.

Zina Affas Besse active positions

Companies	Position	Start
Alydia Health, Inc. Alydia Health, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices	Director/Board Member	-
Eyenuk, Inc. Eyenuk, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diabetic retinopathy diagnostic devices	Director/Board Member	17/10/2022
LHGP Asset Management LLP (Private Equity) LHGP Asset Management LLP (Private Equity) Investment ManagersFinance LHGP Asset Management seeks investment opportunities located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for late stage capital requirements with an average investment size of USD 10 million.	Consultant / Advisor	-
LimmaTech Biologics AG LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases	Director/Board Member	09/10/2023

All active positions of Zina Affas Besse

Training of Zina Affas Besse

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zina Affas Besse's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
LHGP Asset Management LLP (Private Equity) LHGP Asset Management LLP (Private Equity) Investment ManagersFinance LHGP Asset Management seeks investment opportunities located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for late stage capital requirements with an average investment size of USD 10 million.	Finance
Eyenuk, Inc. Eyenuk, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diabetic retinopathy diagnostic devices	Health Technology
Alydia Health, Inc. Alydia Health, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices	Health Technology
LimmaTech Biologics AG LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases	Health Technology
University of Nottingham Malaysia University of Nottingham Malaysia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services